APA

Rubinstein M. M., Hyman D. M., Caird I., Won H., Soldan K., Seier K., Iasonos A., Tew W. P., O'Cearbhaill R. E., Grisham R. N., Hensley M. L., Troso-Sandoval T., Sabbatini P., Guillen J., Selcuklu S. D., Zimel C., Torrisi J., Aghajanian C. & Makker V. (20201009). Phase 2 study of LY3023414 in patients with advanced endometrial cancer harboring activating mutations in the PI3K pathway. : Cancer.

Chicago

Rubinstein Maria M, Hyman David M, Caird Imogen, Won Helen, Soldan Krysten, Seier Kenneth, Iasonos Alexia, Tew William P, O'Cearbhaill Roisin E, Grisham Rachel N, Hensley Martee L, Troso-Sandoval Tiffany, Sabbatini Paul, Guillen Joyce, Selcuklu S Duygu, Zimel Catherine, Torrisi Jean, Aghajanian Carol and Makker Vicky. 20201009. Phase 2 study of LY3023414 in patients with advanced endometrial cancer harboring activating mutations in the PI3K pathway. : Cancer.

Harvard

Rubinstein M. M., Hyman D. M., Caird I., Won H., Soldan K., Seier K., Iasonos A., Tew W. P., O'Cearbhaill R. E., Grisham R. N., Hensley M. L., Troso-Sandoval T., Sabbatini P., Guillen J., Selcuklu S. D., Zimel C., Torrisi J., Aghajanian C. and Makker V. (20201009). Phase 2 study of LY3023414 in patients with advanced endometrial cancer harboring activating mutations in the PI3K pathway. : Cancer.

MLA

Rubinstein Maria M, Hyman David M, Caird Imogen, Won Helen, Soldan Krysten, Seier Kenneth, Iasonos Alexia, Tew William P, O'Cearbhaill Roisin E, Grisham Rachel N, Hensley Martee L, Troso-Sandoval Tiffany, Sabbatini Paul, Guillen Joyce, Selcuklu S Duygu, Zimel Catherine, Torrisi Jean, Aghajanian Carol and Makker Vicky. Phase 2 study of LY3023414 in patients with advanced endometrial cancer harboring activating mutations in the PI3K pathway. : Cancer. 20201009.